...genetic analysis of its kind to date for bipolar d...alance of sodium and calcium in brain cells. Resea... of Mental Health, part of the National Institutes...der and variation in two genes that make component... into and out of cells, including neurons. , "A ...
...ll., Aug. 15 Zebra,Technologies Corporation (Nasd...to a five-year, $100 million revolving credit faci...acility for working capital and general,corporate ...s. The,revolving credit facility has a $100 millio...rease the facility up to a total of $200 million s...
...arnegie Mellon University researchers are urging c...trail of dangerous carbon emissions that are respo...ats. , Because there is no univers...footprint, dozens of carbon calculators have sprun...g confusion and inaccurate information. In additio...
Other Biology News:Largest study of its kind implicates gene abnormalities in bipolar disorder 2Zebra Technologies Enters Into Revolving Credit Agreement to Support Company Growth 2Carnegie Mellon urges industry to broaden carbon footprint calculations 2(Date:11/24/2009)...RNewswire-FirstCall/--Sigma-AldrichCorporation(Nas...eonTuesday,December1stat1:45PMGMTinLondon,7:45AMUS...stovertheInternetavailableat http://inve s tor....st"icontoaccessthisfile. ,, AboutSigma-Aldric...ologycompany.Itschemicalandbiochemicalproductsandk...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq...ingandcommercializingnovelpainmanagementtherapies,...ExecutiveOfficer,isscheduledtopresentatthe21stAnnu...r1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork....lOfficer,willbeavailabletorespondtoquestionsduring...
(Date:11/24/2009)...dpointhasbeenmetforpatientswithadvanced-stage,orre.../PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ:...icalcompanyfocusedonendocrinetherapyandoncology,to...thitstargetedcytotoxicpeptideconjugate,AEZS-108(fo...ometrialcancer.Inapersonalizedhealthcareapproach,t...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--GenomicHealth,Inc....cHealth,sExecutiveChairman,willpresentatthe21stAnn...Tuesday,December1,2009at10:00a.m.ET. ,, Toacces...ation,visittheInvestorRelationssectionofGenomicHea...Pleaseconnecttothewebsiteatleast15minutespriortoth...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2